2L
TECH icon

25 LLC’s Bio-Techne TECH Stock Holding History

25 LLC’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7
Closed -$592 – 504
2023
Q2 		$592 Hold
7
– – ﹤0.01% 405
2023
Q1 		$576 Buy
+7
New +$539 ﹤0.01% 273

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

25 LLC's TECH Position: Q3 2023 in Review

25 LLC sold out of Bio-Techne (TECH) in Q3 2023, closing a stake of 7 shares — an estimated $592 sold.

25 LLC first reported a position in TECH in Q1 2023 and held it in 2 quarters. The position peaked at $592 in Q2 2023. 530 funds tracked by Wall St. Rank hold TECH as of Q3 2023.

  • 25 LLC reported no remaining Bio-Techne position as of Q3 2023 after selling out during the quarter.
  • 25 LLC sold 7 Bio-Techne shares in Q3 2023, an estimated $592.
  • 25 LLC first reported a position in Bio-Techne in Q1 2023 and held it in 2 quarters.
  • 25 LLC's Bio-Techne position peaked at $592 in Q2 2023.
  • 530 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.